HIV/AIDS News

Despite being decades apart, the HIV/AIDS and COVID-19 pandemics shared many lessons that can be applied to future pandemics and health emergencies, Anthony S. Fauci, MD, and his former chief of staff wrote in a new paper.

Fifteen years ago, an HIV vaccine trial conducted in Thailand and sponsored by the U.S. Army found something no other HIV vaccine trial ever had: a regimen that seemed to work.

NEW YORK — In this video, Jacob R. McLean, DO, assistant professor of medicine at Columbia University, recaps his presentation on adolescent STI screening and treatment at the Infectious Diseases in Children Symposium.

LOS ANGELES —In this video from IDWeek, Vani Vannappagari, MBBS, PhD, MPH, global head of epidemiology and real-world evidence at ViiV Healthcare, discusses study findings demonstrating the effectiveness of cabotegravir for HIV prevention.

Less than 3% of patients tested for a bacterial STI in nearly a dozen EDs were also tested for HIV, demonstrating widespread nonadherence to a CDC recommendation, according to a study presented at IDWeek.

A significant number of Medicaid-insured infants infected with HIV in the first year of their life did not receive postnatal antiretroviral prophylaxis, a study presented at IDWeek showed.

LIMA, Peru — Healio is on site for the International AIDS Society’s HIV Research for Prevention Conference, which will take place from Oct. 6 to 10.

Twice-yearly injectable lenacapavir for HIV prevention reduced HIV infections by 96% compared with background HIV incidence and demonstrated superiority over a once-daily pill for PrEP in a phase 3 trial, Gilead Sciences announced Thursday.

HHS this week announced that it will allocate more than $1.4 billion in funding through the Ryan White HIV/AIDS Program to help people with HIV who have low incomes receive medication and care.